iifl-logo-icon 1

Bombay Oxygen Investments Ltd Board Meeting

26,498
(2.50%)
Jul 22, 2024|03:40:00 PM

Bombay Oxygen CORPORATE ACTIONS

23/07/2023calendar-icon
22/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting30 Apr 202422 Apr 2024
Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March 2024 and recommendation of Dividend if any. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.04.2024 till 02.05.2024 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 03.05.2024. Final Dividend & Audited Results (As per BSE Bulletin dated on 22/04/2024) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company was held today i.e. 30th April, 2024, which commenced at 12.30 p.m. and concluded at 3.30 p.m. The meeting inter alia transacted the following business: 1)Audited Financial Results; 2) Dividend; 3) Book Closure; 4) Annual General Meeting; 5(i) Appointment of SCP & Co., Practicing Company Secretaries as the Secretarial Auditors; 5(ii) Re-appointment of Mr. Vikas Mukesh Jain (DIN 09126269), as a Director of the Company liable to retire by rotation.; 5(iii) Appointment of Mr. Swanand Lele, C.A., as an Internal Auditor of the Company with effect from 10th July, 2024 on the existing terms and conditions of his employment. with the Company. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors at its Meeting held on 30th April, 2024 has considered and approved the appointment of SCP & Co., Practicing Company Secretaries as the Secretarial Auditors of the Company, for the financial year ending 31st March, 2025 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors at its Meeting held on 30th April, 2024 has approved the re-appointment of Mr. Vikas Mukesh Jain (DIN 09126269) as a Non-Executive Non-Independent Director of the Company, liable to retire by rotation, subject to the approval of the Members. (As Per BSE Announcement Dated on 30.04.2024)
Board Meeting7 Feb 202429 Jan 2024
Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve the Un-audited Financial Results (Provisional) of the Company for the quarter and nine months ended 31st December 2023. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.01.2024 till 09.02.2024 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 10.02.2024. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 7th February, 2024 which commenced at 12.30 p.m. and concluded at 2.00 p.m. The meeting interalia considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2023 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. (As Per BSE Announcement dated on 07.02.2024)
Board Meeting10 Nov 202331 Oct 2023
Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the Un-audited Financial Results (Provisional) of the Company for the quarter and half year ended 30th September 2023. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.10.2023 till 12.11.2023 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 13.11.2023. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 10th November, 2023 which commenced at 12.30 p.m. and concluded at 2.00 p.m. The meeting interalia considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2023 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have enclosed herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2023 along with the Limited Review Report duly signed by the Statutory Auditors of the Company. The said results were taken on record by the Board at its meeting held on 10th November, 2023. (As Per BSE Announcement Dated on 10/11/2023)
Board Meeting10 Aug 20232 Aug 2023
Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve the Un-audited Financial Results (Provisional) of the Company for the quarter ended 30th June 2023. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.07.2023 till 12.08.2023 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 13.08.2023. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 10th August, 2023 which commenced at 12.30 p.m. and concluded at 2.30 p.m. The meeting inter alia considered and approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2023 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have enclosed herewith a copy of the Unaudited Financial Results for the quarter ended 30th June, 2023 along with Limited Review Report duly signed by the Statutory Auditors of the Company. The said results were taken on record by the Board at its meeting held on 10th August, 2023. (As Per BSE Announcement dated on 10.08.2023)

Bombay Oxygen: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.